Results 271 to 280 of about 285,474 (314)

Endothelin A receptor antagonists in diabetic kidney disease

Current opinion in nephrology and hypertension, 2017
P. Georgianos, R. Agarwal
semanticscholar   +1 more source

Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension

American Journal of Cardiovascular Drugs, 2015
M. Chaumais, C. Guignabert, L. Savale, X. Jaïs, A. Boucly, D. Montani, G. Simonneau, M. Humbert, O. Sitbon   +8 more
semanticscholar   +1 more source

Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

Drug Safety, 2015
M. Aversa, S. Porter, J. Granton
semanticscholar   +1 more source

Pathways and Drugs in Pulmonary Arterial Hypertension – Focus on the Role of Endothelin Receptor Antagonists

Cardiovascular Drugs and Therapy, 2015
R. Madonna, N. Cocco, R. de Caterina
semanticscholar   +1 more source

Endothelin‐receptor antagonists for diabetic nephropathy: A meta‐analysis

Nephrology, 2015
Wen-ming Yuan, Yi Li, J. Wang, Jing Li, Shen-Ju Gou, P. Fu   +5 more
semanticscholar   +1 more source

Endothelin receptor antagonists‐induced hepatotoxicity

Internal Medicine Journal, 2013
D, Macías Saint-Gerons, C, de la Fuente Honrubia, D, Montero, F, Catalá-López   +3 more
openaire   +2 more sources

[Endothelin receptor antagonist].

Nihon rinsho. Japanese journal of clinical medicine, 2000
S, Sakai, T, Miyauchi, Y, Sugishita
openaire   +3 more sources

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Endothelin Receptor Antagonists: New Hope for Renal Protection?

Current Hypertension Reports, 2015
S. Tobe, D. Kohan, Ranjit Singarayer
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly